Free Trial
→ He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (From The Oxford Club) (Ad)
OTCMKTS:EDTXF

Spectral Diagnostics 11/9/2023 Earnings Report

Spectral Diagnostics logo
$0.59 -0.02 (-2.50%)
As of 08/8/2025 03:15 PM Eastern
ProfileEarnings History

Spectral Diagnostics EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Spectral Diagnostics Revenue Results

Actual Revenue
$0.30 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Spectral Diagnostics Announcement Details

Quarter
Date
11/9/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Spectral Diagnostics Earnings Headlines

Spectral Medical Announces Second Quarter and Provides Corporate Update
August 8 at 7:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/08/3130080/0/en/spectral-medical-announces-second-quarter-and-provides-corporate-update.html
Spectral Diagnostics (OTCMKTS:EDTXF) Shares Down 4.8% - Here's Why
August 5, 2025  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30256844
The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
August 9 at 2:00 AM  |  Weiss Ratings (Ad)
Spectral Medical Inc. Announces Filing of Base Shelf Prospectus
July 4, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/04/3110481/0/en/spectral-medical-inc-announces-filing-of-base-shelf-prospectus.html
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders
June 6, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/06/3095233/0/en/spectral-medical-inc-announces-results-of-annual-meeting-of-shareholders.html
Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference
May 16, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/16/3083036/0/en/spectral-medical-to-present-at-the-3rd-annual-h-c-wainwright-bioconnect-investor-conference.html
See More Spectral Diagnostics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Spectral Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Spectral Diagnostics and other key companies, straight to your email.

About Spectral Diagnostics

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics (OTCMKTS:EDTXF) and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

View Spectral Diagnostics Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles